Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002). - Bashey A; Owzar K; Johnson JL; Edwards PS; Kelly M; Baxter-Lowe LA; Devine S; Farag S; Hurd D; Ball E; McCarthy P; Lister J; et al. (Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011)